Search
Naratriptan
go.drugbank.com/drugs/DB00952ApprovedNaratriptan is a triptan drug that is selective for the 5-hydroxytryptamine1 receptor subtype. It is typically used for the treatment of migraine headaches.
Categories: Serotonin-1b and Serotonin-1d Receptor Agonist, Heterocyclic Compounds, 1-RingSynonyms: N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide, N-methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamideTepilamide fumarate
go.drugbank.com/drugs/DB18804InvestigationalSynonyms: (n,n-diethylcarbamoyl)methyl methyl (2e)-but-2-ene-1,4-dioate, 2-(diethylamino)-2-oxoethyl and methyl (2e)-but-2-enedioateTezepelumab
go.drugbank.com/drugs/DB15090ApprovedInvestigationalIt was granted FDA approval on December 17, 2021, and is currently marketed under the trademark TEZSPIRE by Amgen/AstraZeneca. … [L39504] Tezepelumab was also approved by the European Commission on September 19, 2022.[L44712]
Synonyms: AMG 157, AMG-157Products: Tezspire 210 mg/1,91 ml Enjeksiyonluk Çözelti İçeren Kullanıma Hazır Kalem (1 adet)Icatibant
go.drugbank.com/drugs/DB06196ApprovedInvestigational[A4017,A263046] Icatibant was approved by the FDA on August 25, 2011, and by the EMA in 2008 as a treatment for hereditary angioedema. … [L49776,L49781] The FDA approval was based on positive results obtained from 3 double-blind, randomized, controlled clinical trials known as FAST 1, 2, and 3, where a median time to almost complete symptom
Products: İKTU 30 MG/3 ML ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 1 ADET, FIRAZYR 30 MG/3 ML SC ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 1 ADETGentian violet cation
go.drugbank.com/drugs/DB00406ApprovedA dye that is a mixture of violet rosanilinis with antibacterial, antifungal, and anthelmintic properties.
Mixtures: Kerr 100 Triple Dye Dispos-ASynonyms: Crystal violet(1+), Gentian violet(1+)Cardiolipin Biosynthesis CL(10:0/10:0/12:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175348MetabolicCardiolipin biosynthesis occurs mainly in the mitochondria, but there also exists an alternative synthesis route for CDP-diacylglycerol that takes place in the endoplasmic reticulum.
Cardiolipin Biosynthesis CL(10:0/10:0/14:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175409MetabolicCardiolipin biosynthesis occurs mainly in the mitochondria, but there also exists an alternative synthesis route for CDP-diacylglycerol that takes place in the endoplasmic reticulum.
Cardiolipin Biosynthesis CL(10:0/10:0/17:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175480MetabolicCardiolipin biosynthesis occurs mainly in the mitochondria, but there also exists an alternative synthesis route for CDP-diacylglycerol that takes place in the endoplasmic reticulum.
Cardiolipin Biosynthesis CL(10:0/10:0/18:0/18:2(9Z,11Z))
smpdb.ca/view/SMP0175499MetabolicCardiolipin biosynthesis occurs mainly in the mitochondria, but there also exists an alternative synthesis route for CDP-diacylglycerol that takes place in the endoplasmic reticulum.
Cardiolipin Biosynthesis CL(10:0/10:0/18:2(9Z,11Z)/21:0)
smpdb.ca/view/SMP0175518MetabolicCardiolipin biosynthesis occurs mainly in the mitochondria, but there also exists an alternative synthesis route for CDP-diacylglycerol that takes place in the endoplasmic reticulum.